Semi-synthetic bile acid could be a promising therapeutic option for TH17-mediated intestinal diseases Post author:admin Post published:March 15, 2025 Post category:uncategorized A research team from the Medical University of Vienna has made further progress in the treatment of intestinal inflammation. You Might Also Like Prolonged exposure to air pollution linked to elevated risk for ALS January 20, 2026 Age and sex shape Alzheimer’s blood biomarkers, study finds April 22, 2025 Improving medication access in primary care with pharmacy technician support September 22, 2025